Long-term oral contraceptive use increases breast cancer risk in women over 55 years of age: The DOM cohort

被引:0
|
作者
Van Hoften, C
Burger, H
Peeters, PHM
Grobbee, DE
Van Noord, PAH
Leufkens, HGM
机构
[1] Univ Med Ctr Utrecht, Julius Ctr Patient Oriented Res, NL-3508 GA Utrecht, Netherlands
[2] Univ Utrecht, Dept Pharmacoepidemiol & Pharmacotherapy, Utrecht, Netherlands
关键词
D O I
10.1002/1097-0215(20000815)87:4<591::AID-IJC20>3.0.CO;2-C
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The role of past oral contraceptive use in the development of breast cancer is unclear, particularly in postmenopausal women. The authors investigated this relationship among pre- and postmenopausal middle-aged women in a nested case-control study within the population-based DOM cohort, Utrecht, the Netherlands. Among a total population of 12,184 women followed up for an average of 7.5 years, 309 breast cancer cases aged 42 to 63 years, diagnosed from November 1982 through May 1996, and 610 controls were examined. Overall, duration of oval contraceptive use was not clearly related to breast cancer. In women older than 55 years, however, oral contraceptive use for more than 10 years was associated with a 2-fold increased risk of breast cancer (odds ratio (OR) 2.1, 95% confidence interval (CI) 1.1-4.0). We conclude that long duration of oval contraceptive use increases the risk of breast cancer in women over 55 years of age but not in younger women. Int. J. Cancer 87:591-594, 2000. (C) 2000 Wiley-Liss, Inc.
引用
收藏
页码:591 / 594
页数:4
相关论文
共 50 条
  • [1] Long-Term Statin Use and Risk of Ductal and Lobular Breast Cancer among Women 55 to 74 Years of Age
    McDougall, Jean A.
    Malone, Kathleen E.
    Daling, Janet R.
    Cushing-Haugen, Kara L.
    Porter, Peggy L.
    Li, Christopher I.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2013, 22 (09) : 1529 - 1537
  • [2] LONG-TERM ORAL-CONTRACEPTIVE USE AND THE RISK OF BREAST-CANCER
    不详
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1983, 249 (12): : 1591 - 1595
  • [4] Oral contraceptive use in relation to age at menopause in the DOM cohort
    de Vries, E
    den Tonkelaar, I
    van Noord, PAH
    van der Schouw, YT
    te Velde, ER
    Peeters, PHM
    HUMAN REPRODUCTION, 2001, 16 (08) : 1657 - 1662
  • [6] Recent Oral Contraceptive Use by Formulation and Breast Cancer Risk among Women 20 to 49 Years of Age
    Beaber, Elisabeth F.
    Buist, Diana S. M.
    Barlow, William E.
    Malone, Kathleen E.
    Reed, Susan D.
    Li, Christopher I.
    CANCER RESEARCH, 2014, 74 (15) : 4078 - 4089
  • [7] A PROSPECTIVE-STUDY OF LONG-TERM ORAL-CONTRACEPTIVE USE AND RISK OF BREAST-CANCER
    HANKINSON, SE
    WILLETT, WC
    MANSON, JE
    COLDITZ, GA
    HUNTER, DJ
    STAMPFER, MJ
    ROSNER, B
    HENNEKENS, CH
    SPEIZER, FE
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 1995, 141 (11) : S53 - S53
  • [9] Oral contraceptive use and breast cancer risk in women aged 40 years or younger.
    Ursin, G
    Ross, RK
    SullivanHalley, J
    Hanisch, R
    Bernstein, L
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 1996, 143 (11) : 170 - 170
  • [10] Oral contraceptive use and risk of breast cancer among women with a family history of breast cancer: A prospective cohort study
    Silvera, SAN
    Miller, AB
    Rohan, TE
    CANCER CAUSES & CONTROL, 2005, 16 (09) : 1059 - 1063